Page results
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.
-
This step-by-step guide explains how you can give yourself an injection of bortezomib at home.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
-
To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.
File results
-
FOI/2024/0568 - Local Anaesthetic Transperineal Prostate (LATP) biopsy service
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND
-
FOI/2024/0573 - Treatment for haemophilia A and B/ von Willebrand patients
-
FOI/2024/0575 - Replacement or purchase of patient trolleys in 2024/25
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0616 - Never events involving Medical Associate Professionals (MAPs) from 2021/22-2023/24
-
FOI/2024/0612 - Orthotic and prosthetic services at the Trust